Filing Flows

Filing Flows › Companies › Sotera Health › Cash flow

Sotera Health cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$57.7M in Q3 2026 · $135M over twelve months

Operating cash flow$111M
Capital spending−$52.8M
Free cash flow+$57.7M
Cash / net income1.9×
Cash conversion cycle19 days

Analysis

In Q3 2026, Sotera Health generated $111M of operating cash flow and spent $52.8M on capital projects, leaving free cash flow of $57.7M. That is $22.7M more than in Q3 2025 ($35.0M).

Over the twelve months to Sep 30, 2026, operating cash flow was $332M; the largest uses were capital spending ($196M), taxes on employees’ shares ($12.1M), net borrowing (+) / repaid (−) ($10.7M); besides operations, cash came from other investing ($5.3M); the cash balance rose by $111M.

Operating cash flow was $111M against net income of $58.4M — 1.9× profit, cash ran ahead of reported earnings. The largest differences: depreciation & amortization +$32.5M, accrued liabilities +$19.2M, payables −$16.7M.

Its cash conversion cycle was 19 days (receivables 43 + inventory 34 − payables 58).

Free cash flow

Sotera Health: free cash flow by quarterSotera Health: free cash flow by quarter−$10.2MQ4 2024$35.6MQ1 2025$26.2MQ2 2025$35.0MQ3 2025$52.4MQ4 2025−$16.7MQ1 2026$42.0MQ2 2026$57.7MQ3 2026
Operating cash flow less capital spending.
Sotera Health: operating cash flow against capital spendingSotera Health: operating cash flow against capital spendingOperating cash flowCapital spending$55.7M$65.9MQ4 2024$55.5M$19.9MQ1 2025$57.4M$31.2MQ2 2025$71.2M$36.2MQ3 2025$103M$50.7MQ4 2025$29.4M$46.2MQ1 2026$88.5M$46.4MQ2 2026$111M$52.8MQ3 2026
Latest (Q3 2026): Operating cash flow $111M, Capital spending $52.8M.

Capital allocation, year by year

Sotera Health: where the cash came from (up) and went (down), by fiscal yearSotera Health: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingCapital spendingAcquisitionsFY2021: Operating cash flow $282MFY2021: Net borrowing −$101MFY2021: Capital spending −$102MFY2021: Acquisitions −$13.5M$282MFY2021FY2022: Operating cash flow $278MFY2022: Net borrowing $200MFY2022: Capital spending −$182M$478MFY2022FY2023: Operating cash flow −$148MFY2023: Net borrowing $296MFY2023: Capital spending −$215M$296MFY2023FY2024: Operating cash flow $224MFY2024: Net borrowing −$13.1MFY2024: Capital spending −$179M$224MFY2024FY2025: Operating cash flow $287MFY2025: Net borrowing −$90.0MFY2025: Capital spending −$138M$287MFY2025
Over these 5 years operating cash flow totalled $923M; the largest uses were capital spending ($817M) and net borrowing ($204M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$412M
Debt$2.1B
Net debt$1.7B
Due within a year$14.2M

Sotera Health funds itself: free cash flow was $135M over the last twelve months, and $412M of cash and investments stands against $2.1B of debt ($14.2M due within a year, 29.0× covered by cash).

Sotera Health: debt maturities by year (FY2025)Sotera Health: debt maturities by year (FY2025)$14.2MYear 1$14.2MYear 2$14.2MYear 3$14.2MYear 4$14.2MYear 5$2.1BAfter year 5
Principal due in each year as disclosed in the annual report, against $412M of cash and investments now.

Where the cash came from and went

Sotera Health: sources (+) and uses (−) of cash, Q3 2026Sotera Health: sources (+) and uses (−) of cash, Q3 2026Operating cash flow$111MCash drawn (+) / kept (−)−$55.7MCapital spending−$52.8MNet borrowing (+) / repaid (−)−$3.5MOther financing$2.0MExchange rates−$1.3MOther investing$1.1MTaxes on employees’ shares−$285K
Sotera Health: sources (+) and uses (−) of cash, TTM to Q3 2026Sotera Health: sources (+) and uses (−) of cash, TTM to Q3 2026Operating cash flow$332MCapital spending−$196MCash drawn (+) / kept (−)−$111MTaxes on employees’ shares−$12.1MNet borrowing (+) / repaid (−)−$10.7MOther investing$5.3MExchange rates−$4.2MOther financing−$2.4M

From profit to cash

Sotera Health: net income to operating cash flow, Q3 2026Sotera Health: net income to operating cash flow, Q3 2026Net income$58.4MDepreciation & amortization$32.5MStock-based pay$7.7MDeferred taxes$11.4MOther non-cash−$1.5MReceivables−$2.9MInventory$6.9MPayables−$16.7MAccrued liabilities$19.2MPrepaid and other assets−$2.3MOther liabilities−$58KIncome taxes payable−$4.4MOperating cash flow$111M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 202643345819
Q2 202641365620
Q1 202644385230
Q4 202543354731
Q3 202541384336
Q2 202541434836
Q1 202547424742
Q4 202443384634

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q3 2026$111M−$52.8M−$3.5M−$55.7M$57.7M
Q2 2026$88.5M−$46.4M—−$40.8M$42.0M
Q1 2026$29.4M−$46.2M−$3.6M$30.5M−$16.7M
Q4 2025$103M−$50.7M−$3.6M−$45.4M$52.4M
Q3 2025$71.2M−$36.2M−$75.0M$33.2M$35.0M
Q2 2025$57.4M−$31.2M−$3.8M−$28.2M$26.2M
Q1 2025$55.5M−$19.9M−$3.8M−$27.2M$35.6M
Q4 2024$55.7M−$65.9M−$3.8M$29.6M−$10.2M

Sotera Health: income statement and cash flow

Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%. The chart follows the revenue to costs, profit and cash.

Sotera Health: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.